Stock listing
BOATS:VRAX Virax Biolabs Group Limited Stock
US listing (BOATS) of Virax Biolabs Group Limited · home listing NASDAQ:VRAX
Follow Virax Biolabs Group Limited into a list and get an email when it puts out news.
Home listing price · NASDAQ:VRAX
$0.792 USD -0.388 (-32.9%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VRAX
- Day range
- $0.630 – $0.990 USDNov 6, 2026
- Volume
- 1.09M sharesNov 6, 2026
- Market cap
- $1.07M USDAt the close on Nov 6, 2026 · price × 1.34M shares outstanding
- 52-week range
- $0.630 – $21.750 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $1.32M USDMedian day 36,750 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRAX · Home | $0.792 USD | -0.388 (-32.9%) | 1,087,337 | $0.970 | $0.990 | $0.630 | $1.180 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:VRAX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.792 | -0.388 | -32.9% | $0.970 | $0.990 | $0.630 | 1,087,337 | |
| $1.180 | -0.020 | -1.7% | $1.330 | $1.349 | $1.010 | 3,654,966 | |
| $1.200 | +0.140 | +13.2% | $1.160 | $1.570 | $1.110 | 7,752,243 | |
| $1.060 | -0.040 | -3.6% | $1.090 | $1.175 | $1.040 | 33,430 | |
| $1.100 | -0.110 | -9.1% | $1.152 | $1.180 | $1.100 | 24,228 | |
| $1.210 | -0.110 | -8.3% | $1.285 | $1.285 | $1.180 | 23,492 | |
| $1.320 | +0.120 | +10.0% | $1.300 | $1.330 | $1.235 | 57,672 | |
| $1.200 | +0.010 | +0.8% | $1.170 | $1.210 | $1.160 | 10,044 | |
| $1.190 | 0.000 | 0.0% | $1.230 | $1.230 | $1.140 | 11,908 | |
| $1.190 | -0.030 | -2.5% | $1.260 | $1.260 | $1.180 | 10,414 | |
| $1.220 | -0.015 | -1.2% | $1.240 | $1.265 | $1.200 | 33,900 | |
| $1.235 | -0.105 | -7.8% | $1.290 | $1.390 | $1.150 | 38,100 | |
| $1.340 | -0.030 | -2.2% | $1.420 | $1.490 | $1.320 | 14,700 | |
| $1.370 | -0.030 | -2.1% | $1.500 | $1.500 | $1.350 | 13,700 | |
| $1.400 | -0.050 | -3.4% | $1.500 | $1.648 | $1.380 | 12,100 | |
| $1.450 | -0.170 | -10.5% | $1.620 | $1.640 | $1.380 | 40,600 | |
| $1.620 | -0.030 | -1.8% | $1.660 | $1.760 | $1.550 | 44,200 | |
| $1.650 | -0.088 | -5.1% | $1.770 | $1.780 | $1.610 | 38,700 | |
| $1.738 | -0.112 | -6.1% | $1.800 | $1.860 | $1.720 | 39,700 | |
| $1.850 | -0.020 | -1.1% | $1.810 | $1.900 | $1.780 | 71,000 | |
| $1.870 | -0.120 | -6.0% | $1.920 | $1.940 | $1.810 | 87,600 | |
| $1.990 | -0.120 | -5.7% | $2.130 | $2.130 | $1.930 | 50,800 | |
| $2.110 | +0.080 | +3.9% | $2.020 | $2.180 | $1.830 | 271,500 | |
| $2.030 | -0.370 | -15.4% | $2.330 | $2.330 | $1.830 | 310,500 | |
| $2.400 | +0.200 | +9.1% | $2.530 | $3.340 | $2.160 | 2,895,100 | |
| $2.200 | -0.040 | -1.8% | $2.210 | $2.250 | $2.130 | 19,600 | |
| $2.240 | +0.056 | +2.6% | $2.180 | $2.374 | $2.180 | 30,800 | |
| $2.184 | -0.046 | -2.1% | $2.250 | $2.270 | $2.130 | 19,500 | |
| $2.230 | -0.084 | -3.6% | $2.270 | $2.395 | $2.040 | 94,000 | |
| $2.314 | -0.081 | -3.4% | $2.350 | $2.350 | $2.300 | 5,500 | |
| $2.395 | -0.045 | -1.8% | $2.380 | $2.600 | $2.380 | 13,400 | |
| $2.440 | -0.110 | -4.3% | $2.277 | $2.470 | $2.277 | 20,600 | |
| $2.550 | +0.050 | +2.0% | $2.520 | $2.600 | $2.500 | 14,300 | |
| $2.500 | +0.190 | +8.2% | $2.380 | $2.650 | $2.285 | 51,000 | |
| $2.310 | -0.230 | -9.1% | $2.480 | $2.540 | $2.145 | 70,800 | |
| $2.540 | +0.010 | +0.4% | $2.500 | $2.580 | $2.490 | 14,600 | |
| $2.530 | +0.040 | +1.6% | $2.530 | $2.600 | $2.500 | 16,500 | |
| $2.490 | -0.100 | -3.9% | $2.590 | $2.590 | $2.450 | 23,800 | |
| $2.590 | -0.020 | -0.8% | $2.660 | $2.775 | $2.580 | 24,400 | |
| $2.610 | -0.060 | -2.2% | $2.590 | $2.750 | $2.580 | 28,900 | |
| $2.670 | -0.180 | -6.3% | $2.770 | $2.840 | $2.600 | 36,900 | |
| $2.850 | +0.120 | +4.4% | $2.730 | $2.920 | $2.700 | 72,000 | |
| $2.730 | +0.100 | +3.8% | $2.660 | $2.760 | $2.630 | 38,300 | |
| $2.630 | +0.005 | +0.2% | $2.600 | $2.660 | $2.560 | 29,000 | |
| $2.625 | +0.065 | +2.5% | $2.540 | $2.635 | $2.540 | 21,800 | |
| $2.560 | +0.015 | +0.6% | $2.625 | $2.690 | $2.520 | 40,200 | |
| $2.545 | -0.055 | -2.1% | $2.560 | $2.610 | $2.540 | 24,400 | |
| $2.600 | -0.220 | -7.8% | $2.820 | $2.835 | $2.560 | 86,200 | |
| $2.820 | 0.000 | 0.0% | $2.920 | $2.920 | $2.770 | 16,800 | |
| $2.820 | -0.120 | -4.1% | $2.890 | $2.945 | $2.750 | 36,600 | |
| $2.940 | +0.170 | +6.1% | $2.800 | $2.950 | $2.720 | 44,200 | |
| $2.770 | -0.140 | -4.8% | $2.870 | $2.940 | $2.730 | 91,500 | |
| $2.910 | -0.090 | -3.0% | $3.000 | $3.000 | $2.900 | 35,900 | |
| $3.000 | -0.190 | -6.0% | $3.140 | $3.190 | $2.900 | 80,900 | |
| $3.190 | -0.260 | -7.5% | $3.510 | $3.510 | $3.140 | 119,000 | |
| $3.450 | +0.270 | +8.5% | $3.200 | $3.640 | $3.100 | 499,000 | |
| $3.180 | +0.420 | +15.2% | $3.240 | $4.290 | $2.810 | 18,126,600 | |
| $2.760 | -0.050 | -1.8% | $2.780 | $2.820 | $2.760 | 24,100 | |
| $2.810 | -0.050 | -1.7% | $2.810 | $2.835 | $2.800 | 26,600 | |
| $2.860 | +0.040 | +1.4% | $2.849 | $2.890 | $2.780 | 51,300 | |
| $2.820 | +0.040 | +1.4% | $2.760 | $2.890 | $2.710 | 31,400 | |
| $2.780 | -0.090 | -3.1% | $2.890 | $2.890 | $2.760 | 38,300 | |
| $2.870 | -0.010 | -0.3% | $2.830 | $2.910 | $2.830 | 20,500 | |
| $2.880 | -0.100 | -3.4% | $2.990 | $2.990 | $2.790 | 35,700 | |
| $2.980 | +0.210 | +7.6% | $2.810 | $2.981 | $2.710 | 65,200 | |
| $2.770 | -0.140 | -4.8% | $2.760 | $2.907 | $2.740 | 79,600 |
- Ticker
- BOATS:VRAX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Latest news
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Oct 29, 2026
Closed $1.32 (+10.0%) on Oct 29, 2026
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 20, 2026
Closed $3.89 (+2.6%) on Jul 20, 2026
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
Jul 16, 2026
Closed $3.90 (+13.0%) on Jul 16, 2026
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
Jul 10, 2026
Closed $4.07 (-0.2%) on Jul 13, 2026
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
Jul 9, 2026
Closed $6.36 (+100.0%) on Jul 9, 2026
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
Jul 9, 2026
Closed $6.36 (+100.0%) on Jul 9, 2026
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
Jun 24, 2026
Closed $3.30 (-14.8%) on Jun 24, 2026
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
May 26, 2026
Closed $5.68 (-18.3%) on May 26, 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Mar 31, 2026
Closed $5.50 (+35.0%) on Mar 31, 2026
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Dec 4, 2025
Closed $15.75 (-2.2%) on Dec 5, 2025
Financings
Ordinary shares on exercise of preferred investment options
Jul 16, 2026
Closed: US$3.3M in the latest tranche · US$6 a share · Warrants at US$6 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital for general corporate purposes
Announced Jul 9, 2026 · Closed Jul 10, 2026 · Closed Jul 16, 2026
Private placement of ordinary shares (or pre-funded warrants) and preferred investment options
Dec 4, 2025
Closed: US$5M raised · US$0.3999 a share · Warrants at US$0.4 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: General working capital, extending cash runway into the first half of 2028
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026
Investor Presentation (April 2026)
Investor deck · 16 slides · April 2026
IPO Roadshow (July 2022)
IPO roadshow · 23 slides · Jul 1, 2022
Virax Biolabs Group Limited on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 12 in the last 12 months · 46 in all · newest Oct 29, 2026 · oldest 2022
- Decks
- 3 decks · latest September 2026
Where Virax Biolabs Group Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRAX · Home listing | NASDAQ | United States | USD |
| BOATS:VRAX · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Virax Biolabs Group Limited.